 Repressor Proteins
"Repressor Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release.
| Descriptor ID |
D012097
|
| MeSH Number(s) |
D12.776.260.703 D12.776.930.780
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Repressor Proteins".
Below are MeSH descriptors whose meaning is more specific than "Repressor Proteins".
This graph shows the total number of publications written about "Repressor Proteins" by people in this website by year, and whether "Repressor Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 | | 1996 | 1 | 2 | 3 | | 1997 | 6 | 0 | 6 | | 1998 | 3 | 1 | 4 | | 1999 | 2 | 4 | 6 | | 2000 | 1 | 5 | 6 | | 2001 | 7 | 4 | 11 | | 2002 | 10 | 3 | 13 | | 2003 | 3 | 0 | 3 | | 2004 | 6 | 4 | 10 | | 2005 | 3 | 4 | 7 | | 2006 | 9 | 1 | 10 | | 2007 | 7 | 6 | 13 | | 2008 | 4 | 8 | 12 | | 2009 | 9 | 0 | 9 | | 2010 | 6 | 10 | 16 | | 2011 | 10 | 7 | 17 | | 2012 | 7 | 10 | 17 | | 2013 | 10 | 11 | 21 | | 2014 | 12 | 7 | 19 | | 2015 | 13 | 3 | 16 | | 2016 | 7 | 2 | 9 | | 2017 | 6 | 9 | 15 | | 2018 | 8 | 6 | 14 | | 2019 | 6 | 2 | 8 | | 2020 | 6 | 2 | 8 | | 2021 | 6 | 1 | 7 | | 2022 | 2 | 6 | 8 | | 2023 | 0 | 3 | 3 | | 2024 | 3 | 3 | 6 | | 2025 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Repressor Proteins" by people in Profiles.
-
Darmusey L, Bagley AJ, Nguyen TT, Carlson HL, Blaylock H, Shrestha SB, Pang A, Tauchmann S, Taylor SC, Foley AC, Ni?o KE, Pietras EM, Braun TP, Maxson JE. Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation. Blood Adv. 2025 Apr 08; 9(7):1593-1607.
-
Biswas S, Lee JE, Xie G, Masclef L, Ren Z, C?t? J, Affar EB, Ge K, Kutateladze TG. Colorectal cancer hot spot mutations attenuate the ASXL-MLL4 interaction. J Biol Chem. 2025 Mar; 301(3):108333.
-
Oguh AU, Haemmerle MW, Sen S, Rozo AV, Shrestha S, Cartailler JP, Fazelinia H, Ding H, Preza S, Yang J, Yang X, Sussel L, Alvarez-Dominguez JR, Doliba N, Spruce LA, Arrojo E Drigo R, Stoffers DA. E3 ligase substrate adaptor SPOP fine-tunes the UPR of pancreatic ? cells. Genes Dev. 2025 Feb 03; 39(3-4):261-279.
-
Singh S, Arya G, Mishra R, Singla S, Pratap A, Upadhayay K, Sharma M, Chaba R. Molecular mechanisms underlying allosteric behavior of Escherichia coli DgoR, a GntR/FadR family transcriptional regulator. Nucleic Acids Res. 2025 Jan 07; 53(1).
-
Leydon AR, Downing B, Solano Sanchez J, Loll-Krippleber R, Belliveau NM, Rodriguez-Mias RA, Bauer AJ, Watson IJ, Bae L, Vill?n J, Brown GW, Nemhauser JL. A function of TPL/TBL1-type corepressors is to nucleate the assembly of the preinitiation complex. J Cell Biol. 2025 Feb 03; 224(2).
-
Chakraborty S, Cheng BY, Edwards DL, Gonzalez JC, Chiu DK, Zheng H, Scallan C, Guo X, Tan GS, Coffey GP, Conley PB, Hume PS, Janssen WJ, Byers DE, Mudd PA, Taubenberger J, Memoli M, Davis MM, Chua KF, Diamond MS, Andreakos E, Khatri P, Wang TT. Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease. Immunity. 2025 Jan 14; 58(1):182-196.e10.
-
Eckhardt CM, Balte P, Morris JE, Bhatt SP, Couper D, Fetterman J, Freedman N, Jacobs DR, Hou L, Kalhan R, Liu Y, Loehr L, Lutsey PL, Schwartz JE, White W, Yende S, London SJ, Sanchez TR, Oelsner EC. Non-cigarette tobacco products, aryl-hydrocarbon receptor repressor gene methylation and smoking-related health outcomes. Thorax. 2024 Oct 16; 79(11):1060-1068.
-
Ravi J, Samart K, Zwolak J. Modeling the START transition in the budding yeast cell cycle. PLoS Comput Biol. 2024 Aug; 20(8):e1012048.
-
Zhang Y, Xie G, Lee JE, Zandian M, Sudarshan D, Estavoyer B, Benz C, Viita T, Asgaritarghi G, Lachance C, Messmer C, Simonetti L, Sinha VK, Lambert JP, Chen YW, Wang SP, Ivarsson Y, Affar EB, C?t? J, Ge K, Kutateladze TG. ASXLs binding to the PHD2/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers. Nat Commun. 2024 Jun 07; 15(1):4883.
-
Weaver AN, Iams WT, Park JC, Mita M, Holtick U, Gordon MS, Rodabaugh KJ, Dhani N, Neupane P, Taylor M, Amanda Duvall E, Jennings J, Miselis NR, Loughhead S, Warren MS, Bernstein H, Klussmann JP, Baranda J, Jimeno A. Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration. Mol Carcinog. 2024 Aug; 63(8):1421-1428.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|